In addition to clinicopathological prognostic features, several immunohistochemical markers, such as CD44, MMP-2, and MMP-9, have been investigated as potential prognosticators for ccRCC [7,8,9]. This evidence concerns the gene CD44 and nonpapillary renal cell carcinoma.